National Cancer Institute - NCI Division of Cancer Treatment and ...
National Cancer Institute - NCI Division of Cancer Treatment and ... National Cancer Institute - NCI Division of Cancer Treatment and ...
Developmental Therapeutics Program, continued Natural Products Branch Dr. David Newman Acting Branch Chief Ms. Erma Brown Administrative Program Assistant Dr. Gordon Cragg Special Volunteer Pharmaceutical Resources Branch Dr. Babu Rao Vishnuvajjala Branch Chief Dr. James Cradock Pharmacologist Dr. Shanker Gupta Pharmacist Dr. Sung Kim Chemist Dr. Paul Liu Chemist Dr. Raj Narain Misra Chemist Dr. Esmail Tabibi Chemist Screening Technologies Branch Dr. Robert Shoemaker Branch Chief Dr. John Cardellina, II Senior Disciplinary Scientist Dr. David Covell Computer Scientist Dr. Michael Currens Pharmacologist Dr. Constance Glover Research Chemist Mr. Glenn Gray Chemist Ms. Susan Kenney Biologist Dr. Sudhir Kondapaka Biologist Dr. Susan Mertins Biologist Dr. David Vistica Pharmacologist Dr. Giovanni Melillo Tumor Hypoxia [Contractor] Dr. Anne Monks Functional Genomics [Contractor] Dr. Dominic Scudiero In Vitro Cell Line Screening [Contractor] Dr. Anders Wallquist Computational Tools for Cancer [Contractor] D C T D R O S T E R ■ 137
Developmental Therapeutics Program, continued 138 ■ P R O G R A M A C C O M P L I S H M E N T S 2 0 0 6 Toxicology and Pharmacology Branch Dr. Joseph Tomaszewski Branch Chief Ms. Ruoli Bai Chemist, Tubulin Lab Dr. Joseph Covey Pharmacologist Dr. Susan Donohue Toxicologist Dr. Elizabeth Glaze Toxicologist Dr. Ernest Hamel Senior Disciplinary Scientist, Tubulin Lab Dr. Lee Jia Pharmacologist Dr. James Peggins Toxicologist Dr. Karen Schweikart Toxicologist Dr. Nicola Smith Pharmacologist Vacant Office Director, DCTD Project Management Office Mr. Tiziano DiPaolo Project Manager, DCTD Project Management Office [Contractor] Dr. William Jacob Senior Project Manager, DCTD Project Management Office [Contractor] Ms. Vali Sevastita Science Writer, DCTD Project Management Office [Contractor] Dr. Melanie Simpson Project Manager, Project Management Office [Contractor] Dr. Ralph Parchment Director, Laboratory of Human Toxicology and Pharmacology (LHTP) [Contractor] Dr. Robert Kinders Head, LHTP, Pharmacodynamic Assay Development and Implementation Section (PADIS) [Contractor] Mr. Sonny Khin LHTP, PADIS [Contractor] Ms. Kristine Robillard LHTP, PADIS [Contractor] Dr. Lihua Wang Scientist, LHTP, PADIS [Contractor] Mr. Weiman Zhu LHTP, PADIS [Contractor] Dr. Shizuko Sei Scientist, LHTP, Viral Vector Toxicology Section [Contractor] Dr. Sherry Yang Chief, National Clinical Target Validation Laboratory (NCTVL) Dr. Jiuping (Jay) Ji Scientist, NCTVL [Contractor] Mr. Sylvan McDowell Senior Research Technician, NCTVL [Contractor] Dr. Yiping Zhang Scientist, NCTVL [Contractor]
- Page 91 and 92: Oxaliplatin-Based Regimen Permits S
- Page 93 and 94: egular checkups to look for lymph-n
- Page 95 and 96: NCI Visuals Online. Human lymphoma
- Page 97 and 98: T O O L S , P R O D U C T S , A N D
- Page 99 and 100: ■ Clinical Trials Monitoring Bran
- Page 101 and 102: DTP’s staff and administered gran
- Page 103 and 104: therapeutics. Proposed exploratory
- Page 105 and 106: M A J O R O N G O I N G I N I T I A
- Page 107 and 108: National Cancer Institute. discover
- Page 109 and 110: C U R R E N T F U N D I N G O P P O
- Page 111 and 112: DTP oversees animal-production faci
- Page 113 and 114: disease can require considerable in
- Page 115 and 116: National Cancer Institute. commerci
- Page 117 and 118: The Type 1 Diabetes Rapid Access to
- Page 119 and 120: H I S T O R Y - M A R K I N G E V E
- Page 121 and 122: With this approach, patients are no
- Page 123 and 124: This included a camptothecin deriva
- Page 125 and 126: RRP supports research involving a v
- Page 127 and 128: Laredo Medical Center, Laredo, TX h
- Page 129 and 130: With TELESYNERGY® as a link, healt
- Page 131 and 132: Radiation Bioterrorism Research and
- Page 133 and 134: Enhanced Radiosensitivity The Molec
- Page 135 and 136: M E E T I N G S A N D W O R K S H O
- Page 137 and 138: Cancer Imaging Program 132 ■ P R
- Page 139 and 140: Cancer Therapy Evaluation Program,
- Page 141: Developmental Therapeutics Program,
Developmental Therapeutics Program, continued<br />
Natural Products Branch<br />
Dr. David Newman Acting Branch Chief<br />
Ms. Erma Brown Administrative Program Assistant<br />
Dr. Gordon Cragg Special Volunteer<br />
Pharmaceutical Resources Branch<br />
Dr. Babu Rao Vishnuvajjala Branch Chief<br />
Dr. James Cradock Pharmacologist<br />
Dr. Shanker Gupta Pharmacist<br />
Dr. Sung Kim Chemist<br />
Dr. Paul Liu Chemist<br />
Dr. Raj Narain Misra Chemist<br />
Dr. Esmail Tabibi Chemist<br />
Screening Technologies Branch<br />
Dr. Robert Shoemaker Branch Chief<br />
Dr. John Cardellina, II Senior Disciplinary Scientist<br />
Dr. David Covell Computer Scientist<br />
Dr. Michael Currens Pharmacologist<br />
Dr. Constance Glover Research Chemist<br />
Mr. Glenn Gray Chemist<br />
Ms. Susan Kenney Biologist<br />
Dr. Sudhir Kondapaka Biologist<br />
Dr. Susan Mertins Biologist<br />
Dr. David Vistica Pharmacologist<br />
Dr. Giovanni Melillo Tumor Hypoxia [Contractor]<br />
Dr. Anne Monks Functional Genomics [Contractor]<br />
Dr. Dominic Scudiero In Vitro Cell Line Screening [Contractor]<br />
Dr. Anders Wallquist Computational Tools for <strong>Cancer</strong> [Contractor]<br />
D C T D R O S T E R ■ 137
Change language